Skip to main content
. 2014 Jun 20;30(2):139–144. doi: 10.1177/1533317514539540

Table 1.

Selected Demographic and Clinical Characteristics of Patients According to MMSE Score at 6 Months of Evaluation.

Quantitative variables MMSE < 20 MMSE > 20
Nonresponders Responders P Nonresponders Responders P
N Mean SD N Mean SD N Mean SD N Mean SD
Age, years 25 82.960 7.191 60 80.267 6.994 .112 39 79.795 6.856 53 79.887 5.999 .946
Education, years 24 3.292 2.053 60 3.600 2.763 .623 39 4.205 2.597 53 5.623 4.161 .064
Concomitant diseases 24 2.375 1.439 58 2.707 1.214 .290 38 2.789 1.189 52 2.692 1.292 .716
Concomitant therapies, number of drugs 23 3.913 3.014 57 4.614 2.343 .269 37 4.324 2.286 51 4.353 2.726 .959
Years of AD 25 6.240 2.818 59 5.593 2.614 .314 39 6.026 2.323 53 5.226 2.407 .114
MMSE score at baseline 25 15.400 2.828 60 15.167 3.179 .751 39 23.051 2.695 53 23.000 2.139 .919
MMSE scores after 6 months of treatment 25 12.880 2.774 60 17.950 4.127 <.001 39 20.051 2.883 53 24.226 2.318 <.001
MMSE scores after 12 months of treatment 20 13.250 4.315 56 17.036 4.584 .002 38 20.763 3.132 50 23.860 3.169 <.001
IADL 21 14.095 3.897 55 15.309 5.480 .357 34 17.912 5.276 48 18.896 5.058 .396
ADL 22 4.636 1.364 57 4.491 1.754 .698 32 5.094 1.445 49 5.347 1.071 .368
Qualitative variables Nonresponders Responders P* Nonresponders Responders P*
Sex, n (%) F—21 (84.0%) F—50 (83.3%) .940 F—28 (71.8%) F—31 (58.5%) .189
M—4 (16.0%) M—10 (16.7%) M—11 (28.3%) M—22 (41.5%)
BPSD presence, n (%) No 2 (9.1%) No 7 (13.7%) .580 No 13 (36.1%) No 11 (21.2%) .121
Yes 20 (90.9%) Yes 44 (86.3%) Yes 23 (63.9%) Yes 41 (78.8%)

Abbreviations: n, number of individuals; BPSD, behavioral and psychological symptoms of dementia; MMSE, Mini-Mental State Examination; IADL, Instrumental Activities of Daily Living; ADL, Activities of Daily Living; SD, standard deviation; AD, Alzheimer’s disease; P, P value obtained by Student’s t test; P*, P value obtained by chi-square test; F, female; M, male.